Southern Magnesium and Chemicals Limited (BOM:513498)
India
· Delayed Price · Currency is INR 89.10
-2.73 (-2.97%)
At close: Apr 28, 2026
BOM:513498 Revenue
Southern Magnesium and Chemicals had revenue of 5.82M INR in the quarter ending December 31, 2025, a decrease of -66.53%. This brings the company's revenue in the last twelve months to 32.69M, down -77.09% year-over-year. In the fiscal year ending March 31, 2025, Southern Magnesium and Chemicals had annual revenue of 124.36M with 31.34% growth.
Revenue (ttm)
32.69M
Revenue Growth
-77.09%
P/S Ratio
8.35
Revenue / Employee
1.05M
Employees
31
Market Cap
273.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 124.36M | 29.68M | 31.34% |
| Mar 31, 2024 | 94.68M | 8.99M | 10.49% |
| Mar 31, 2023 | 85.70M | 62.32M | 266.60% |
| Mar 31, 2022 | 23.38M | 3.25M | 16.16% |
| Mar 31, 2021 | 20.12M | 4.27M | 26.91% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Intec Capital | 119.87M |
| MPIL Corporation | 600.00K |
| Megri Soft | 26.82M |
| Deccan Health Care | 816.77M |
| Jindal Capital | 35.68M |
| Navigant Corporate Advisors | 62.77M |
| Accedere | 33.71M |
| Span Divergent | 131.28M |